- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.40 Å
- Oligo State
- homo-trimer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.6: 4 residues within 4Å:- Chain A: N.1084, T.1086, H.1087, F.1089
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.7: 1 residues within 4Å:- Chain A: N.1120
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 3 residues within 4Å:- Chain B: N.1084, H.1087, F.1089
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.20: 4 residues within 4Å:- Chain C: N.1084, T.1086, H.1087, F.1089
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.21: 1 residues within 4Å:- Chain C: N.1120
No protein-ligand interaction detected (PLIP)- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.22: 4 residues within 4Å:- Chain A: N.109, A.110, T.111, N.112
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: C.2, V.3, N.4
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: D.325, F.328, N.329
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: Y.15, N.48
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: N.589, T.590
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.643
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: N.602, Q.630
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: N.695
- Chain B: Y.782
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.132, S.240
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: C.2, N.4, N.124
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: D.325, N.329, L.357
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: Y.15, N.48
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.589
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.643
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: N.602, Q.630
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.695
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: N.109, A.110, N.112
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: N.4, N.124
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain C: N.329, V.353, L.354, L.357
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: Y.15, N.48
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain C: N.589
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: Y.641, N.643
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: N.602, Q.630
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain A: Y.782
- Chain C: N.695
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cui, Z. et al., Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell (2022)
- Release Date
- 2022-05-18
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.40 Å
- Oligo State
- homo-trimer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cui, Z. et al., Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell (2022)
- Release Date
- 2022-05-18
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C